Angion Biomedica Corp logo

ANGN

Angion Biomedica Corp

$1

Earnings Summary

Revenue
$0Mn
Net Profits
$-4.47Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Angion Biomedica Corp’s revenue fell -100% since last year same period to $0Mn in the Q1 2023. On a quarterly growth basis, Angion Biomedica Corp has generated -100% fall in its revenue since last 3-months.

Net Profits:

Angion Biomedica Corp’s net profit jumped 68.63% since last year same period to $-4.47Mn in the Q1 2023. On a quarterly growth basis, Angion Biomedica Corp has generated 85.02% jump in its net profits since last 3-months.

Net Profit Margins:

Angion Biomedica Corp’s net profit margin fell -Inf% since last year same period to -Inf% in the Q1 2023. On a quarterly growth basis, Angion Biomedica Corp has generated -Inf% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Angion Biomedica Corp post its latest quarter earnings

EPS Estimate Current Quarter
-0.29
EPS Estimate Current Year
-0.29

Highlights

EPS Estimate Current Quarter:

Angion Biomedica Corp’s earning per share (EPS) estimates for the current quarter stand at -0.29 - a 19.44% jump from last quarter’s estimates.

EPS Estimate Current Year:

Angion Biomedica Corp’s earning per share (EPS) estimates for the current year stand at -0.29.

Key Ratios

Key ratios of the Angion Biomedica Corp post its Q1 2023 earnings

Return on Assets (ROA)
-0.21
Return on Equity (ROE)
-0.54

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Angion Biomedica Corp’s return on assets (ROA) stands at -0.21.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Angion Biomedica Corp’s return on equity (ROE) stands at -0.54.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-11-14
-0.36
-0.3
16.67%
2022-05-16
-0.43
-0.48
-11.63%
2022-08-15
-0.46
-0.3
34.78%